Fmr LLC Has $548.73 Million Stock Position in DocuSign, Inc. (NASDAQ:DOCU)

FMR LLC increased its stake in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 178.2% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,101,024 shares of the company's stock after acquiring an additional 3,908,139 shares during the period. FMR LLC owned about 3.02% of DocuSign worth $548,726,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp raised its stake in shares of DocuSign by 2.3% during the 3rd quarter. State Street Corp now owns 5,372,939 shares of the company's stock worth $333,604,000 after purchasing an additional 120,743 shares in the last quarter. American Century Companies Inc. increased its holdings in DocuSign by 18.5% during the fourth quarter. American Century Companies Inc. now owns 5,315,459 shares of the company's stock worth $478,072,000 after buying an additional 831,611 shares during the last quarter. Geode Capital Management LLC raised its position in DocuSign by 7.2% during the fourth quarter. Geode Capital Management LLC now owns 3,732,363 shares of the company's stock worth $335,147,000 after acquiring an additional 249,179 shares in the last quarter. Norges Bank acquired a new stake in DocuSign in the fourth quarter valued at $223,196,000. Finally, Thrivent Financial for Lutherans lifted its stake in DocuSign by 1.8% in the fourth quarter. Thrivent Financial for Lutherans now owns 2,318,137 shares of the company's stock valued at $208,494,000 after acquiring an additional 40,825 shares during the last quarter. Institutional investors own 77.64% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on DOCU. UBS Group dropped their target price on shares of DocuSign from $100.00 to $90.00 and set a "neutral" rating on the stock in a report on Friday, March 14th. Wells Fargo & Company upped their price objective on shares of DocuSign from $70.00 to $73.00 and gave the company an "underweight" rating in a report on Friday, March 14th. William Blair upgraded shares of DocuSign from a "market perform" rating to an "outperform" rating in a research note on Monday, March 17th. Needham & Company LLC reiterated a "hold" rating on shares of DocuSign in a research note on Friday, March 14th. Finally, Royal Bank of Canada restated a "sector perform" rating and set a $90.00 price objective on shares of DocuSign in a research report on Friday, March 14th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $93.85.

DocuSign Stock Performance

Shares of DocuSign stock traded up $2.34 on Monday, reaching $76.69. 438,031 shares of the stock were exchanged, compared to its average volume of 2,719,226. The firm's 50 day moving average is $82.95 and its 200-day moving average is $82.90. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86. The firm has a market cap of $15.53 billion, a PE ratio of 15.81, a P/E/G ratio of 6.94 and a beta of 1.20.

DocuSign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings results on Thursday, March 13th. The company reported $0.86 earnings per share for the quarter, beating analysts' consensus estimates of $0.84 by $0.02. The company had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a net margin of 34.73% and a return on equity of 14.90%. The firm's quarterly revenue was up 9.0% compared to the same quarter last year. During the same period last year, the company posted $0.76 EPS. On average, equities research analysts expect that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.

Insider Buying and Selling at DocuSign

In related news, Director Teresa Briggs sold 534 shares of the stock in a transaction on Monday, March 17th. The stock was sold at an average price of $87.41, for a total value of $46,676.94. Following the completion of the sale, the director now directly owns 8,270 shares in the company, valued at $722,880.70. This represents a 6.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider James P. Shaughnessy sold 7,500 shares of DocuSign stock in a transaction that occurred on Tuesday, April 1st. The stock was sold at an average price of $81.31, for a total value of $609,825.00. Following the completion of the transaction, the insider now directly owns 45,875 shares in the company, valued at approximately $3,730,096.25. This represents a 14.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 47,851 shares of company stock worth $3,998,719. 1.66% of the stock is currently owned by insiders.

About DocuSign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.